Abstract
Minocycline, a semi-synthetic second-generation derivative of tetracycline, has been reported to exert neuroprotective effects both in animal models and in clinic trials of neurological diseases. In the present study, we first investigated the protective effects of minocycline on oxygen-glucose deprivation and reoxygenation-induced impairment of neurite outgrowth and its potential mechanism in the neuronal cell line, PC12 cells. We found that minocycline significantly increased cell viability, promoted neurite outgrowth and enhanced the expression of growth-associated protein-43 (GAP-43) in PC12 cells exposed to oxygen-glucose deprivation/reoxygenation injury. In addition, immunoblots revealed that minocycline reversed the overexpression of phosphorylated myosin light chain (MLC) and the suppression of activated extracellular signal-regulated kinase 1/2 (ERK1/2) caused by oxygen-glucose deprivation/reoxygenation injury. Moreover, the minocycline-induced neurite outgrowth was significantly blocked by Calyculin A (1 nM), an inhibitor of myosin light chain phosphatase (MLCP), but not by an ERK1/2 inhibitor (U0126; 10 μM). These findings suggested that minocycline activated the MLCP/MLC signaling pathway in PC12 cells after oxygen-glucose deprivation/reoxygenation injury, which resulted in the promotion of neurite outgrowth.
Similar content being viewed by others
References
Alabed YZ, Grados-Munro E, Ferraro GB, Hsieh SH, Fournier AE (2006) Neuronal responses to myelin are mediated by rho kinase. J Neurochem 96(6):1616–1625
Antonenko YN, Rokitskaya TI, Cooper AJ, Krasnikov BF (2010) Minocycline chelates Ca2+, binds to membranes, and depolarizes mitochondria by formation of Ca2+-dependent ion channels. J Bioenerg Biomembr 42(2):151–163
Atwal JK, Pinkston-Gosse J, Syken J, Stawicki S, Wu Y, Shatz C, Tessier-Lavigne M (2008) PirB is a functional receptor for myelin inhibitors of axonal regeneration. Science 322(5903):967–970
Cafferty WB, McGee AW, Strittmatter SM (2008) Axonal growth therapeutics: regeneration or sprouting or plasticity? Trends Neurosci 31(5):215–220. doi:10.1016/j.tins.2008.02.004
Chen MS, Huber AB, van der Haar ME, Frank M, Schnell L, Spillmann AA, Christ F, Schwab ME (2000) Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403(6768):434–439
Chen X, Chen S, Jiang Y, Zhu C, Wu A, Ma X, Peng F, Ma L, Zhu D, Wang Q, Pi R (2013) Minocycline reduces oxygen-glucose deprivation-induced PC12 cell cytotoxicity via matrix metalloproteinase-9, integrin beta1 and phosphorylated Akt modulation. Neurol Sci 34(8):1391–1396
Choi DH, Lee KH, Kim JH, Kim MY, Lim JH, Lee J (2012) Effect of 710 nm visible light irradiation on neurite outgrowth in primary rat cortical neurons following ischemic insult. Biochem Biophys Res Commun 422(2):274–279
Das KP, Freudenrich TM, Mundy WR (2004) Assessment of PC12 cell differentiation and neurite growth: a comparison of morphological and neurochemical measures. Neurotoxicol Teratol 26(3):397–406
El Omri A, Han J, Kawada K, Ben Abdrabbah M, Isoda H (2012) Luteolin enhances cholinergic activities in PC12 cells through ERK1/2 and PI3 K/Akt pathways. Brain Res 1437:16–25
Endo M, Yamashita T (2009) Inactivation of Ras by p120GAP via focal adhesion kinase dephosphorylation mediates RGMa-induced growth cone collapse. J Neurosci 29(20):6649–6662
Fabian L, Troscianczuk J, Forer A (2007) Calyculin A, an enhancer of myosin, speeds up anaphase chromosome movement. Cell Chromosome 6:1
Fagan SC, Cronic LE, Hess DC (2011) Minocycline development for acute ischemic stroke. Transl Stroke Res 2(2):202–208
Fan X, Lo EH, Wang X (2013) Effects of minocycline plus tissue plasminogen activator combination therapy after focal embolic stroke in type 1 diabetic rats. Stroke 44(3):745–752
Fournier AE, GrandPre T, Strittmatter SM (2001) Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 409(6818):341–346
Fujita A, Hattori Y, Takeuchi T, Kamata Y, Hata F (2001) NGF induces neurite outgrowth via a decrease in phosphorylation of myosin light chain in PC12 cells. NeuroReport 12(16):3599–3602
Garcia-Martinez EM, Sanz-Blasco S, Karachitos A, Bandez MJ, Fernandez-Gomez FJ, Perez-Alvarez S, de Mera RM, Jordan MJ, Aguirre N, Galindo MF, Villalobos C, Navarro A, Kmita H, Jordan J (2010) Mitochondria and calcium flux as targets of neuroprotection caused by minocycline in cerebellar granule cells. Biochem Pharmacol 79(2):239–250
Gonzenbach RR, Schwab ME (2008) Disinhibition of neurite growth to repair the injured adult CNS: focusing on Nogo. Cell Mol Life Sci CMLS 65(1):161–176
GrandPre T, Nakamura F, Vartanian T, Strittmatter SM (2000) Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 403(6768):439–444
Hashimoto K, Ishima T (2010) A novel target of action of minocycline in NGF-induced neurite outgrowth in PC12 cells: translation initiation [corrected] factor eIF4AI. PLoS ONE 5(11):e15430
Heasman SJ, Ridley AJ (2008) Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat Rev Mol Cell Biol 9(9):690–701
Inutsuka A, Goda M, Fujiyoshi Y (2009) Calyculin A-induced neurite retraction is critically dependent on actomyosin activation but not on polymerization state of microtubules. Biochem Biophys Res Commun 390(4):1160–1166
Kelly-Hayes M, Beiser A, Kase CS, Scaramucci A, D’Agostino RB, Wolf PA (2003) The influence of gender and age on disability following ischemic stroke: the Framingham study. J Stroke Cerebrovas Dis 12(3):119–126
Kikuchi K, Kawahara K, Biswas KK, Ito T, Tancharoen S, Morimoto Y, Matsuda F, Oyama Y, Takenouchi K, Miura N, Arimura N, Nawa Y, Meng X, Shrestha B, Arimura S, Iwata M, Mera K, Sameshima H, Ohno Y, Maenosono R, Yoshida Y, Tajima Y, Uchikado H, Kuramoto T, Nakayama K, Shigemori M, Hashiguchi T, Maruyama I (2009) Minocycline attenuates both OGD-induced HMGB1 release and HMGB1-induced cell death in ischemic neuronal injury in PC12 cells. Biochem Biophys Res Commun 385(2):132–136
Kim HS, Suh YH (2009) Minocycline and neurodegenerative diseases. Behav Brain Res 196(2):168–179
Kitayama M, Ueno M, Itakura T, Yamashita T (2011) Activated microglia inhibit axonal growth through RGMa. PLoS ONE 6(9):e25234
Kubo T, Endo M, Hata K, Taniguchi J, Kitajo K, Tomura S, Yamaguchi A, Mueller BK, Yamashita T (2008) Myosin IIA is required for neurite outgrowth inhibition produced by repulsive guidance molecule. J Neurochem 105(1):113–126
Lampl Y, Boaz M, Gilad R, Lorberboym M, Dabby R, Rapoport A, Anca-Hershkowitz M, Sadeh M (2007) Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology 69(14):1404–1410
McKerracher L, David S, Jackson DL, Kottis V, Dunn RJ, Braun PE (1994) Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron 13(4):805–811
Nagahara Y, Suzuki E, Sekine Y, Uchiro H, Yoshimi Y, Shinomiya T, Ikekita M (2012) SUTAF, a novel beta-methoxyacrylate derivative, promotes neurite outgrowth with extracellular signal-regulated kinase and c-jun N-terminal kinase activation. Eur J Pharmacol 694(1–3):53–59
Plane JM, Shen Y, Pleasure DE, Deng W (2010) Prospects for minocycline neuroprotection. Arch Neurol 67(12):1442–1448
Reber BF, Bouron A (1995) Calyculin-A-induced fast neurite retraction in nerve growth factor-differentiated rat pheochromocytoma (PC12) cells. Neurosci Lett 183(3):198–201
Singh G, Siddiqui MA, Khanna VK, Kashyap MP, Yadav S, Gupta YK, Pant KK, Pant AB (2009) Oxygen glucose deprivation model of cerebral stroke in PC-12 cells: glucose as a limiting factor. Toxicol Mech Methods 19(2):154–160
Song Y, Wei EQ, Zhang WP, Zhang L, Liu JR, Chen Z (2004) Minocycline protects PC12 cells from ischemic-like injury and inhibits 5-lipoxygenase activation. NeuroReport 15(14):2181–2184
Stirling DP, Koochesfahani KM, Steeves JD, Tetzlaff W (2005) Minocycline as a neuroprotective agent. Neuroscientist 11(4):308–322
Suter DM, Forscher P (2000) Substrate-cytoskeletal coupling as a mechanism for the regulation of growth cone motility and guidance. J Neurobiol 44(2):97–113
Tan HB, Zhong YS, Cheng Y, Shen X (2011) Rho/ROCK pathway and neural regeneration: a potential therapeutic target for central nervous system and optic nerve damage. Int J Ophthalmol 4(6):652–657
Tao T, Xu G, SiChen C, Feng J, Kong Y, Qin X (2013) Minocycline promotes axonal regeneration through suppression of RGMa in rat MCAO/reperfusion model. Synapse 67(4):189–198
Walsh MP, Cole WC (2013) The role of actin filament dynamics in the myogenic response of cerebral resistance arteries. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 33(1):1–12
Wang KC, Koprivica V, Kim JA, Sivasankaran R, Guo Y, Neve RL, He Z (2002) Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 417(6892):941–944
Wang YH, Wang DW, Wu N, Wang Y, Yin ZQ (2012) Alpha-crystallin promotes rat axonal regeneration through regulation of RhoA/rock/cofilin/MLC signaling pathways. J Mol Neurosci MN 46(1):138–144
Yong VW, Wells J, Giuliani F, Casha S, Power C, Metz LM (2004) The promise of minocycline in neurology. Lancet Neurol 3(12):744–751
Zhou Y, Besner GE (2010) Heparin-binding epidermal growth factor-like growth factor is a potent neurotrophic factor for PC12 cells. Neuro-Signals 18(3):141–151
Acknowledgments
These studies were supported by the National Natural Science Foundation of China (Nos: 30770762, 30970987) to Dr. Xin-Yue Qin, a grant from the Health Department of Sichuan Province (No: 140032), and from the Doctoral Fund of affiliated hospital of Luzhou Medical College (No: 2014046) to Dr. Tao Tao.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare there is no conflict of interest.
Rights and permissions
About this article
Cite this article
Tao, T., Feng, Jz., Xu, Gh. et al. Minocycline Promotes Neurite Outgrowth of PC12 Cells Exposed to Oxygen-Glucose Deprivation and Reoxygenation Through Regulation of MLCP/MLC Signaling Pathways. Cell Mol Neurobiol 37, 417–426 (2017). https://doi.org/10.1007/s10571-016-0374-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-016-0374-z